AEON Biopharma Initiates Enrollment in Phase 2 Trial of ABP-450 for the Preventive Treatment of Migraine

NEXT STORY
Sensus Healthcare to Participate in Three Investment Conferences During the Month of March
PREV STORY
Race Against Time: Steps to Address SDOH to Establish Community Immunity
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

EDAP TMS SA : Urologic Oncologists from Top US Teaching Hospitals Gather in Montreal to Learn Advanced Prostate Sparing Medical Procedure

MONTREAL, QUEBEC - OCTOBER 24, 2018 - Urologists, uro-oncologists and urology department chairs from ...

author_avatar
NASDAQ Market News

Teneobio Announces US FDA Clearance of Investigational New Drug Application for TNB-486 and the Initiation of Phase I Clinical Studies in Patients with B-cell Malignancies

author_avatar
NASDAQ Market News

IBA SA : IBA annonce ses résultats annuels consolidés pour 2017

IBA annonce ses résultats annuels consolidés pour 2017 Louvain-La-Neuve, Belgique, 22 mars, 2018 - IBA ...

author_avatar
NASDAQ Market News